Arrowstreet Capital’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$556K Buy
+49,536
New +$556K ﹤0.01% 1732
2024
Q3
Sell
-59,861
Closed -$292K 1887
2024
Q2
$292K Sell
59,861
-7,835
-12% -$38.2K ﹤0.01% 1402
2024
Q1
$899K Buy
+67,696
New +$899K ﹤0.01% 1342